Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25
These health concerns have raised serious questions about the drugs safety, and now, Ozempic lawsuits filed across the country claim that drug manufacturers failed to adequately warn users of these health risks
Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
At the time of this publication, both subcutaneous liraglutide and semaglutide (2.4 mg weekly dose) are TGA approved for chronic weight management in Australia
The MHRA said that between 2007 and October 2025 it received 1,296 Yellow Card reports of pancreatitis associated with these medicines, including 19 that involved a patient fatality and 24 reports of necrotising pancreatitis
A 24-week Phase II trial was conducted at five obesity centers in Denmark to assess the efficacy and safety of TE in treating obesity
Catalpol protects against spinal cord injury in mice through regulating MicroRNA-142-Mediated HMGB1/TLR4/NF-B signaling pathway
